The data showed that curcumol inhibits NPC invasion and metastasis in association with the ubiquitin-conjugating enzyme E2C (UBE2C), a potential target for anti-EBV-positive NPC therapy. Here, UBE2C is linked to nasopharyngeal carcinoma.